Friday, July 10, 2026

Drug profile · INN

iodipamide meglumine

iodipamide meglumine (CHOLOGRAFIN MEGLUMINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — iodipamide meglumine
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

iodipamide meglumine (CHOLOGRAFIN MEGLUMINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN iodipamide meglumine
Brand CHOLOGRAFIN MEGLUMINE
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is iodipamide meglumine?

iodipamide meglumine (CHOLOGRAFIN MEGLUMINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for iodipamide meglumine?

CHOLOGRAFIN MEGLUMINE is a marketed brand name for iodipamide meglumine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of iodipamide meglumine?

iodipamide meglumine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.